Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Proto-Oncogene Proteins. Found 46 abstracts

no pagination
Pei J, Zhao X, Patchefsky AS, Flieder DB, Talarchek JN, Testa JR, Wei S. Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience. Medicine. 2019 Jun;98(25):e16031.   PMCID: PMC6636967
Good CR, Madzo J, Patel B, Maegawa S, Engel N, Jelinek J, Issa JJ. A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer. Nucleic acids research. 2017 Aug 21;45(14):8269-81.   PMCID: PMC5737541
Zhang M, Lin J, Wang S, Cheng Z, Hu J, Wang T, Man W, Yin T, Guo W, Gao E, Reiter RJ, Wang H, Sun D. Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling. Journal of pineal research. 2017 Sep;63(2).
Hochster HS, Uboha N, Messersmith W, Gold PJ, O Neil BH, Cohen D, Denlinger C, Cohen S, Leichman CG, Leichman L, Lenz HJ. Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer. Cancer Chemother Pharmacol. 2015 Jan;75(1):17-23.
Hooper R, Zhang X, Webster M, Go C, Kedra J, Marchbank K, Gill DL, Weeraratna AT, Trebak M, Soboloff J. Novel Protein Kinase C-Mediated Control of Orai1 Function in Invasive Melanoma. Mol Cell Biol. 2015 Aug;35(16):2790-8.   PMCID: 4508319
Jin C, Qin T, Barton MC, Jelinek J, Issa JP. Minimal role of base excision repair in TET-induced global DNA demethylation in HEK293T cells. Epigenetics. 2015 Jan;10(11):1006-13.   PMCID: PMC4844212
Yamazaki J, Taby R, Jelinek J, Raynal NJ, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Issa JP. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia. Journal of the National Cancer Institute. 2015 Nov 13;108(2).   PMCID: 4862435
Paliwal A, Temkin AM, Kerkel K, Yale A, Yotova I, Drost N, Lax S, Nhan-Chang CL, Powell C, Borczuk A, Aviv A, Wapner R, Chen X, Nagy PL, Schork N, Do C, Torkamani A, Tycko B. Comparative Anatomy of Chromosomal Domains with Imprinted and Non-Imprinted Allele-Specific DNA Methylation. Plos Genetics. 2013 Aug;9(8):e1003622.   PMCID: PMC 3757050
Huang H, Yen TJ. BubR1 is an effector of multiple mitotic kinases that specifies kinetochore: microtubule attachments and checkpoint. Cell cycle (Georgetown, Tex). 2009 Apr 15;8(8):1164-7.
van Slegtenhorst M, Khabibullin D, Hartman TR, Nicolas E, Kruger WD, Henske EP. The Birt-Hogg-Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe. The Journal of biological chemistry. 2007 Aug 24;282(34):24583-90.
Bellacosa A, Kumar CC, Di Cristofano A, Testa JR. Activation of AKT kinases in cancer: implications for therapeutic targeting. Advances in cancer research. 2005 Jan;94:29-86.
Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004 Jul 29;23(34):5853-7.
Badawi AF, Liu Y, Eldeen MB, Morrow W, Razak ZR, Maradeo M, Badr MZ. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate. Carcinogenesis. 2004 Sep;25(9):1681-8.
Bellacosa A, Testa JR, Moore R, Larue L. A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities. Cancer Biol Ther. 2004 Mar;3(3):268-75.
Maier H, Ostraat R, Gao H, Fields S, Shinton SA, Medina KL, Ikawa T, Murre C, Singh H, Hardy RR, Hagman J. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nature immunology. 2004 Oct;5(10):1069-77.
Altomare DA, Tanno S, De Rienzo A, Klein-Szanto AJ, Skele KL, Hoffman JP, Testa JR. Frequent activation of AKT2 kinase in human pancreatic carcinomas. Journal of cellular biochemistry. 2003 Jan;88(1):470-6.
Balogh GA, Russo IH, Russo J. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells. International Journal of Oncology. 2003 Aug;23(2):411-9.
Hardy RR. B-cell commitment: deciding on the players. Current Opinion in Immunology. 2003 Apr;15(2):158-65.
Pankov R, Cukierman E, Clark K, Matsumoto K, Hahn C, Poulin B, Yamada KM. Specific beta1 integrin site selectively regulates Akt/protein kinase B signaling via local activation of protein phosphatase 2A. The Journal of biological chemistry. 2003 May 16;278(20):18671-81.
Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol. 2002 Nov;22(22):7831-41.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Proto-Oncogene Proteins

Proto-Oncogene Proteins metabolism genetics Mice Protein-Serine-Threonine Kinases Signal Transduction Male Female US Gov't Support-PHS Human Phosphorylation DNA Methylation physiology 0 (Proto-Oncogene Proteins) Mutation Middle Aged 1-Phosphatidylinositol 3-Kinase Transcription Factors pathology pa [Pathology] Adult Enzyme Activation Molecular Sequence Data enzymology pharmacology Tumor Suppressor Proteins Cell Line Amino Acid Sequence Neoplasm Proteins Apoptosis Neoplasms Rats chemistry DNA Repair DNA-Binding Proteins Phosphoric Monoester Hydrolases B-Lymphocytes Binding Sites Mixed Function Oxygenases Neoplastic Gene Expression Regulation Non-US Gov't Support Tumor Cell Line Amino Acid Sequence Homology HEK293 Cells Protein Kinase C ge [Genetics] Membrane Proteins me [Metabolism] Western Blotting Alleles Proto-Oncogene Proteins c-bcl-2 Protein Kinases Messenger) 0 (RNA Cell Proliferation Biological Models Cultured Tumor Cells Inbred C57BL Mice Aged Oncogene Proteins Proto-Oncogene Proteins c-akt CpG Islands Messenger RNA DNA Damage SCID Mice Precipitin Tests Macrolides Sirtuin 3 base excision repair Cytoplasm Trans-Activators HeLa Cells Flow Cytometry human) EC 3-6-1 (PMS2 protein Complementary DNA Biological Markers EC 2-7-1-37 (Protein-Serine-Threonine Kinases) Melanoma DNA replication Phosphoprotein Phosphatase 0 (Biological Markers) zebrafish) 0 (wnt8b protein Fungal Gene Expression Regulation Protein p53 DNA-(Apurinic or Apyrimidinic Site) Lyase Survival Analysis Canavanine Cell Enlargement Melatonin EC 1-14-99 (cyclooxygenase 2) CD29 Antigens Soft Tissue Neoplasms Camptothecin CDC2 Protein Kinase Cisplatin mammalian) 0 (MLH1 protein Recombinant Fusion Proteins Non-US Gov't Research Support Breast Neoplasms Inbred F344 Rats EC 2-7-1-137 (1-Phosphatidylinositol 3-Kinase) 0 (Chromones) EC 2-7-1 (protein kinase C alpha) mortality Genomic Imprinting 0 (Wnt proteins) cy [Cytology] Gamma Rays Aging Schizosaccharomyces pombe Proteins Immunohistochemistry use Schizosaccharomyces Pancreatic Neoplasms ai [Antagonists & Inhibitors] DNA Repair Enzymes Tumor Biomarkers Dinoprostone deficiency EC 3-6-1-3 (Adenosinetriphosphatase) Sarcoma US Gov't Research Support-PHS Thymine DNA Glycosylase ras Proteins therapy Reverse Transcriptase Polymerase Chain Reaction EC 2-7-1-37 (Protein Kinases) 0 (Morpholines) 0 (Neoplasm Proteins) Mitogen-Activated Protein Kinases biosynthesis drug effects EC 6-5-1 (DNA Repair Enzymes) therapeutic Protein Isoforms adverse Myeloid Leukemia-Acute Transformed Cell Line Isoenzymes Adenosinetriphosphatase methods physiopathology Xenopus Embryonic Stem Cells Adenocarcinoma Microtubules 0 (Isoenzymes) Genetic Polymorphism DNA demethylation pathway Cell Division Cell Survival
Last updated on Wednesday, August 12, 2020